Jubilant Ingrevia Limited. Q4 results show revenue fell from 1165.31 to 1153.98 crores, a 0.97% decrease in growth. EPS also dropped from ₹52.31 to ₹91.53, down by 42.85%.
First, Let’s Begin with Quarter-on-Quarter Basis:
Jubilant Ingrevia Ltd. shared its Q4 results on Tuesday. They earned 1153.98 crores in revenue this quarter, but that’s less than the 1165.31 crores they made last quarter. Unfortunately, the company’s growth decreased by 0.97 percent when comparing the two quarters.
In terms of profits, Jubilant Ingrevia Ltd’s PAT (Profit After Tax) for this quarter was 52.31 crores, down from 91.53 crores in the previous quarter. Their quarter-to-quarter growth declined by 42.85 percent.
The company’s EPS (Earnings Per Share) this quarter is ₹3.29, which is a decrease of 42.78% from the ₹5.75 EPS in the previous quarter.
Also read: ☞ ” Indian Oil Corporation Q4FY23 Results: Consolidated PAT Up at Rs 10289.82 Cr “
Now, Let’s Analyze the Results on a Year-over-Year Basis:
The company made a total revenue of 4806.06 crores this year (2023), which is 3.51 percent lower than last year’s total revenue of 4980.85 crores.
This year’s PAT (Profit After Tax) is 307.50 crores, which is also 35.50% lower than last year’s PAT of 476.71 crores.
The EPS (Earnings Per Share) for this year is ₹19.33, which is 35.50% less than the EPS of ₹29.97 earned last year.
The company earns the most revenue from its retail and telecom segments, which are its two major revenue sources.
Jubilant Ingrevia Share Dividend Announcement / Record Date:
The Board of Directors has declared a Final Dividend of ₹2.5 per Equity Share of Face Value of ₹1 each of the Company (250% of Face Value). Total Dividend for FY23 stood at ₹5 per Equity Share (Interim Dividend of ₹1 per Equity Share)
| Dividend | Record Date |
| ₹2.5 per Equity Share | Coming Soon |
The record date for the dividend has not arrived yet.
About Jubilant Ingrevia:
Jubilant Ingrevia is a worldwide integrated provider of life science products and innovative solutions. We cater to a diverse range of industries including pharmaceuticals, nutrition, agrochemicals, consumer goods, and industrial sectors. Our offerings consist of customized products and solutions that are known for their innovation, cost-effectiveness, and adherence to high-quality standards.
Download Full PDF Q4 Results of Jubilant Ingrevia: Click Here
For more of the Latest News, Click Here
One thought on “Jubilant Ingrevia Q4FY23 Results: Consolidated PAT of Rs 52.31 Cr”